Nephroprotection by SGLT2 Inhibition: Back to the Future?

The introduction of sodium/glucose cotransporter 2 inhibitors (SGLT2i) has opened new perspectives for the management of diabetic population at risk of or with chronic kidney disease (CKD). More important, recent, large real-world studies have repositioned the nephroprotective efficacy of SGLT2i eme...

Descripción completa

Detalles Bibliográficos
Autores principales: De Nicola, Luca, Gabbai, Francis B., Garofalo, Carlo, Conte, Giuseppe, Minutolo, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408701/
https://www.ncbi.nlm.nih.gov/pubmed/32679744
http://dx.doi.org/10.3390/jcm9072243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408701/
https://www.ncbi.nlm.nih.gov/pubmed/32679744
http://dx.doi.org/10.3390/jcm9072243

Ejemplares similares